Catalogo dei prodotti della ricerca

BARONE, EUGENIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.270
EU - Europa 1.316
AS - Asia 599
SA - Sud America 31
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 6.242
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.237
IT - Italia 770
SG - Singapore 252
CN - Cina 156
IN - India 137
SE - Svezia 130
UA - Ucraina 99
FI - Finlandia 63
GB - Regno Unito 56
DE - Germania 38
FR - Francia 30
ID - Indonesia 30
CA - Canada 28
AR - Argentina 27
NL - Olanda 23
CH - Svizzera 19
BG - Bulgaria 17
BE - Belgio 16
IE - Irlanda 16
TG - Togo 16
PT - Portogallo 12
HK - Hong Kong 6
PK - Pakistan 5
PL - Polonia 5
JP - Giappone 4
LT - Lituania 4
MX - Messico 4
RO - Romania 4
AL - Albania 3
BR - Brasile 3
SC - Seychelles 3
SI - Slovenia 3
EE - Estonia 2
ES - Italia 2
EU - Europa 2
KR - Corea 2
NG - Nigeria 2
TH - Thailandia 2
TR - Turchia 2
ZA - Sudafrica 2
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
GL - Groenlandia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 6.242
Salva come PNG Salva come JPEG
Città #
Fairfield 783
Ashburn 368
Woodbridge 355
Rome 350
Seattle 307
Cambridge 275
Chandler 268
Houston 262
Wilmington 250
Singapore 177
Ann Arbor 168
Princeton 95
San Paolo di Civitate 95
Lawrence 79
Plano 62
Beijing 54
Boston 52
Fasano 44
San Diego 44
Dearborn 43
Millbury 41
Norwalk 38
New York 35
Jakarta 30
Jacksonville 29
Federal 27
Santa Clara 25
Milan 24
Andover 22
Boardman 21
Toronto 18
Brussels 16
Dublin 16
Lomé 16
Des Moines 15
Florence 15
Sofia 14
Mannheim 12
Palermo 12
Falls Church 11
Naples 11
Amsterdam 10
London 10
Basildon 9
Coimbra 9
Geneva 9
Hefei 9
Munich 8
Ottawa 8
Redwood City 8
Chicago 7
Helsinki 7
Kunming 7
Nanjing 7
San Mateo 7
Auburn Hills 6
Dallas 6
Nanchang 6
Bühl 5
Islamabad 5
Lappeenranta 5
St Louis 5
Casarano 4
Ferentino 4
Lanciano 4
Las Vegas 4
Los Angeles 4
Monfalcone 4
Paris 4
Parmain 4
Phoenix 4
Rimini 4
Rochester 4
Salerno 4
Zhengzhou 4
Alatri 3
Bern 3
Casale Monferrato 3
Catania 3
Cernobbio 3
Chengdu 3
Cisterna di Latina 3
Edinburgh 3
Formia 3
Fuzhou 3
Guangzhou 3
Mahé 3
Rende 3
San Francisco 3
Santa Cruz 3
Tirana 3
Wuhan 3
Abbiategrasso 2
Ariccia 2
Bangkok 2
Bialystok 2
Bremen 2
Buffalo 2
Carrollton 2
Ercolano 2
Totale 4.851
Salva come PNG Salva come JPEG
Nome #
Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity 141
Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease 131
Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain 125
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease 120
Curcumin and alzheimer disease: this marriage is not to be performed 115
Lack of p53 Decreases Basal Oxidative Stress Levels in the Brain Through Upregulation of Thioredoxin-1, Biliverdin Reductase-A, Manganese Superoxide Dismutase, and Nuclear Factor Kappa-B 114
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome 113
Bach1 overexpression in down syndrome correlates with the alteration of the ho-1/bvr-a system: insights for transition to Alzheimer's disease 109
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome 108
Activation of p53 in down syndrome and in the ts65dn mouse brain is associated with a pro-apoptotic phenotype 106
Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of down's syndrome 105
Intranasal administration of KYCCSRK peptide rescues brain insulin signaling activation and reduces Alzheimer’s disease-like neuropathology in a mouse model for Down syndrome 103
HO-1/BVR-A system analysis in plasma from probable Alzheimer's disease and mild cognitive impairment subjects: A potential biochemical marker for the prediction of the disease 102
Impairment of biliverdin reductase-a promotes brain insulin resistance in Alzheimer disease: a new paradigm 101
Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment 100
Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: implications for Alzheimer disease 97
Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: novel hints on immunosenescence and biomarker detection 93
Neuropathological role of pi3k/akt/mtor axis in Down syndrome brain 92
Inactivation of brain Cofilin-1 by age, Alzheimer's disease and γ-secretase 91
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome 91
It is all about (U)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer disease 89
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease 89
Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease 88
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation 88
Cholesterol-independent neuroprotective and neurotoxic activities of statins: Perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders 87
Disturbance of redox homeostasis in down syndrome: role of iron dysmetabolism 84
Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways 83
Statins more than cholesterol lowering agents in Alzheimer disease: Their pleiotropic functions as potential therapeutic targets. 80
The triangle of death in Alzheimer's disease brain: the aberrant cross-talk among energy metabolism, mammalian target of rapamycin signaling, and protein homeostasis revealed by redox proteomics 80
Polyubiquitinylation profile in down syndrome brain before and after the development of Alzheimer neuropathology 79
The heme oxygenase/biliverdin reductase pathway in drug research and development 78
High-fat diet leads to reduced protein o-glcnacylation and mitochondrial defects promoting the development of Alzheimer’s disease signatures 78
Inhibition of lipid peroxidation and protein oxidation by endogenous and exogenous antioxidants in rat brain microsomes in vitro 77
Poly-ubiquitin profile in Alzheimer disease brain 75
Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment 74
Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: a harmful synergistic path in down syndrome 74
Curcumin in clinical practice: myth or reality? 73
Heme oxygenase-derived carbon monoxide modulates gonadotropin-releasing hormone release in immortalized hypothalamic neurons 73
Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53 73
Sex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusion. 70
Coenzyme Q10 and cognition in atorvastatin treated dogs 70
The BACH1/Nrf2 axis in brain in down syndrome and transition to alzheimer disease-like neuropathology and dementia 70
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease 70
In vivo protective effect of ferulic acid against noise-induced hearing loss in the guinea-pig 69
Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus 68
Early and selective activation and subsequent alterations to the unfolded protein response in down syndrome mouse models 65
Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects 65
Therapeutic use of tea derivatives: All that glitters is not gold 64
Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants 64
null 64
The dysregulation of OGT/OGA cycle mediates Tau and APP neuropathology in down syndrome 64
Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles 64
The protective role of carotenoids against 7-keto-cholesterol formation in solution 63
Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control 63
Synthesis, characterization, and anti-inflammatory activity of diclofenac-bound cotton fibers 62
HNE-modified proteins in Down syndrome: involvement in development of Alzheimer disease neuropathology 62
Ferulic acid and its therapeutic potential as a hormetin for age-related diseases 61
Pharmacologists and Alzheimer disease therapy: To boldly go where no scientist has gone before 60
Natural substances and Alzheimer's disease: From preclinical studies to evidence based medicine 59
Chronic perk induction promotes alzheimer-like neuropathology in down syndrome: Insights for therapeutic intervention 59
Redox Proteomics Analyses of the Influence of Co-Expression of Wild-Type or Mutated LRRK2 and Tau on C. elegans Protein Expression and Oxidative Modification: Relevance to Parkinson Disease 58
Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. 58
Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain 58
Lack of p53 Affects the Expression of Several Brain Mitochondrial Proteins: Insights from Proteomics into Important Pathways Regulated by p53 57
Oxidative and Nitrosative Modifications of Biliverdin Reductase-A in the Brain of Subjects with Alzheimer’s Disease and Amnestic Mild Cognitive Impairment 57
Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: A novel mechanism of action 56
CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down syndrome 55
Characterization of the S-denitrosylating activity of bilirubin. 54
Experimental research on nitric oxide and the therapy of alzheimer disease: A challenging bridge 53
Reduced biliverdin reductase-a expression in visceral adipose tissue is associated with adipocyte dysfunction and nafld in human obesity 53
Aberrant protein networks in Alzheimer disease 52
Editorial: Oxidative stress and Alzheimer disease: where do we stand? 51
BVR-A deficiency leads to autophagy impairment through the dysregulation of AMPK/mTOR axis in the brain—Implications for neurodegeneration 51
Proteomics study of peripheral blood mononuclear cells in down syndrome children 50
null 49
Heme oxygenase expression and activity in immortalized hypothalamic neurons GT1-7 48
Down syndrome Is a metabolic disease: altered Insulin signaling mediates peripheral and brain dysfunctions 46
Behavioural and neuropathological effects of intranasal insulin treatment in a triple-transgenic mouse model of Alzheimer's disease (3xTg-AD) 45
Biliverdin Reductase-A correlates with inducible nitric oxide synthasein in atorvastatin treated aged canine brain. 41
Dynamic changes of BVRA protein levels occur in response to insulin: a pilot study in humans 40
Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes 40
Heme oxygenase-1 in central nervous system malignancies 38
Borsa miglior poster 35
Biliverdin reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3β 34
Brain insulin resistance: An early risk factor for Alzheimer's disease development in down syndrome 32
Editorial: Brain insulin resistance in neurodevelopmental and neurodegenerative disorders: mind the gap! 31
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease 31
Building the future therapies for down syndrome: the third international conference of the T21 research society 29
mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder 27
Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signaling 26
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome 25
Role of biliverdin reductase A in the regulation of insulin signaling in metabolic and neurodegenerative diseases: An update 24
Valorization of tomato waste as a source of carotenoids 21
Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model 21
Engineering memory with an extrinsically disordered kinase 19
A bioengineering strategy to control ADAM10 activity in living cells 16
Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome 15
Insulin Signaling Regulates Mitochondrial Bioenergetics in the Brain: Insight for the Development of Neurodegenerative Diseases 12
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology 12
Altered Brain Cholesterol Machinery in a Down Syndrome Mouse Model: A Possible Common Feature with Alzheimer’s Disease 11
Totale 6.566
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.271
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.271
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.120 0 0 0 0 153 186 218 192 165 106 51 49
2020/2021637 48 59 38 22 29 29 32 36 83 178 62 21
2021/20221.116 68 70 115 28 95 48 43 125 77 70 187 190
2022/20231.068 163 259 61 124 94 83 35 69 102 18 42 18
2023/2024631 47 78 29 40 65 120 30 25 7 47 62 81
2024/2025463 62 93 109 135 64 0 0 0 0 0 0 0
Totale 6.571